Indaptus Therapeutics, Inc.
INDP· Nasdaq
Released May 8, 2024, before the open
10-Q filed May 8, 2024, 38 days after period end · 0001493152-24-018162
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$3.81M | -$4.25M | -$3.37M | -$612.42K |
| EPS Diluted | -$0.45 | -$0.51 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Indaptus Therapeutics, Inc. · CIK 1857044 · Engraved from SEC EDGAR